Sometimes, less really is more. By removing oxygen during synthesis, a team led by materials scientists at Penn State has ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...
Operational review for the quarter ended 30 September 2025 Delivering operational and project excellence into a constructive commodity price environment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results